Top Markets
#1 Pleasing Gold Pleasing Gold +1,496.37%
#2 PulseChain PulseChain +58.12%
#3 Ontology Gas Ontology Gas +37.96%
#4 Merlin's Seal BTC Merlin's Seal BTC +33.44%
#5 BOOK OF MEME BOOK OF MEME +30.66%
#6 Unit Pump Unit Pump +25.83%
#7 Pump.fun Pump.fun +25.83%
#8 Neiro Neiro +25.36%
#9 ConstitutionDAO ConstitutionDAO +23.34%
#10 Collect on Fanable Collect on Fanable +23.27%
Coin of the day
Pleasing Gold Pleasing Gold
設定
言語
日本
通貨
USD
テーマ
Molecure S.A. Molecure S.A.

Molecure S.A.

MOC
株式のランク #26169
Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in... Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in the research, development, and commercialization of innovative therapies designed to combat neoplastic (cancer) and inflammatory conditions. The company's pipeline prominently features OATD-01, a chitotriosidase/acidic mammalian chitinase inhibitor that has successfully advanced through Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and sarcoidosis. Additionally, Molecure is progressing its YKL-40 program for cancer and fibrosis, OATD-02 for oncology applications, and a Deubiquitinase program. Established in 2012, this Warsaw-headquartered enterprise adopted the name Molecure S.A. in March 2022, having previously been known as OncoArendi Therapeutics S.A.
株価
$1.73
時価総額
$42.88M
変化（1日）
2.16%
変化（1年）
-18.85%
国
PL
取引 Molecure S.A. (MOC)

カテゴリー

Healthcare
Molecure S.A.（MOC）の利益
2026 時点の利益 TTM: 0
Molecure S.A. の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Molecure S.A. の利益の推移（2026 〜 2026）
各年末の利益
年 利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益
企業 利益 利益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US